GIPR and neoplasm: In 2013, Sherman et al. pointed out that GIPR is a promising target for NET imaging and therapy due to its favorable expression pattern17 and the feasibility of GIPR targeting was shown in a GIPR over-expressing tumor model using a truncated GIP1-30 analogue18.